SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950168-03-000969
Filing Date
2003-03-27
Accepted
2003-03-27 16:29:14
Documents
3
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 SALIX PHARMACEUTICALS, LTD. d10k.htm 10-K 763245
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1814
4 CERTIFICATIONS PURSUANT TO SARBANES-OXLEY ACT dex991.htm EX-99.1 5712
  Complete submission text file 0000950168-03-000969.txt   772636
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23265 | Film No.: 03621307
SIC: 2834 Pharmaceutical Preparations